References
- World Health OrganizationWorld Health StatisticsGenevaWorld Health Organization2008
- Tobacco Control Office, Department of HealthSmoking Cessation InformationHong KongTobacco Control Office, Department of Health2015
- LimSLamDCMuttalifARImpact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based surveyAsia Pac Fam Med2015141425937817
- Chan-YeungMLaiCKChanKSHong Kong Thoracic SocietyThe burden of lung disease in Hong Kong: a report from the Hong Kong Thoracic SocietyRespirology200813suppl 4S133S16518945323
- JencksSFWilliamsMVColemanEARehospitalizations among patients in the Medicare fee-for-service programN Engl J Med2009360141418142819339721
- ShahTChurpekMMCoca PerraillonMKonetzkaRTUnderstanding why patients with COPD get readmitted: a large national study to delineate the Medicare population for the readmissions penalty expansionChest201514751219122625539483
- global initiative for chronic obstructive lung disease (GOLD). CommitteeGlobal Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease2011 Available from: http://www.goldcopd.org/Guidelines/guidelines-resources.htmlAccessed August 13, 2013
- EdepMEShahNBTateoIMMassieBMDifferences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelinesJ Am Coll Cardiol19973025185269247527
- SharifRCuevasCRWangYAroraMSharmaGGuideline adherence in management of stable chronic obstructive pulmonary diseaseRespir Med201310771046105223639271
- Centers for Disease Control and Prevention (CDC)Chronic obstructive pulmonary disease and associated health-care resource use – North Carolina, 2007 and 2009MMWR Morb Mortal Wkly Rep201261814314622377845
- PriceDWestDBrusselleGManagement of COPD in the UK primary-care setting: an analysis of real-life prescribing patternsInt J Chron Obstruct Pulmon Dis2014988990425210450
- PerezXWisniveskyJPLurslurchachaiLKleinmanLCKronishIMBarriers to adherence to COPD guidelines among primary care providersRespir Med2012106337438122000501
- SalinasGDWilliamsonJCKalhanRBarriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physiciansInt J Chron Obstruct Pulmon Dis2011617117921468169
- ChiangCHLiuSLChuangCHJhengYHEffects of guideline-oriented pharmacotherapy in patients with newly diagnosed COPD: a prospective studyWien Klin Wochenschr201312513–1435336123817861
- AscheCVLeaderSPlauschinatCAdherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroidsInt J Chron Obstruct Pulmon Dis2012720120922500120
- DivoMCoteCde TorresJPBODE Collaborative GroupComorbidities and risk of mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012186215516122561964
- AuLHChanHSSeverity of airflow limitation, co-morbidities and management of chronic obstructive pulmonary disease patients acutely admitted to hospitalHong Kong Med J201319649850323784531
- MiravitllesMMurioCTirado-CondeGGeographic differences in clinical characteristics and management of COPD: the EPOCA studyInt J Chron Obstruct Pulmon Dis20083480381419281096
- MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
- QuanjerPHStanojevicSColeTJMulti-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equationsEur Respir J20124061324134322743675
- Regional COPD Working GroupCOPD prevalence in 12 Asia-Pacific countries and regions: projections based on the COPD prevalence estimation modelRespirology20038219219812753535
- TuranOEmreJCDenizSBaysakATuranPAMiriciAAdherence to current COPD Guidelines in TurkeyExpert Opin Pharmacother201617215315826629809
- CalverleyPMAndersonJACelliBTORCH InvestigatorsSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
- TashkinDPCelliBSennSUPLIFT Study InvestigatorsA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
- WedzichaJABanerjiDChapmanKRFLAME InvestigatorsIndacaterol–glycopyrronium versus salmeterol–fluticasone for COPDN Engl J Med2016374232222223427181606
- MaioSBaldacciSMartiniFCOMODHES Study GroupCOPD management according to old and new GOLD guidelines: an observational study with Italian general practitionersCurr Med Res Opin20143061033104224450467
- MiravitllesMSicrasACrespoCCosts of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care settingTher Adv Respir Dis20137313915023653458
- PapalaMKerenidiNGourgoulianisKIEveryday clinical practice and its relationship to 2010 and 2011 GOLD guideline recommendations for the management of COPDPrim Care Respir J201322336236423989678
- SpencerSKarnerCCatesCJEvansDJInhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary diseaseCochrane Database Syst Rev2011712CD007033
- KewKMSeniukovichAInhaled steroids and risk of pneumonia for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20143CD01011524615270
- CabanaMDRandCSPoweNRWhy don’t physicians follow clinical practice guidelines? A framework for improvementJAMA1999282151458146510535437
- DesaluOOOnyedumCCAdeotiAOGuideline-based COPD management in a resource-limited setting – physicians’ understanding, adherence and barriers: a cross-sectional survey of internal and family medicine hospital-based physicians in NigeriaPrim Care Respir J2013221798523443222
- OveringtonJDHuangYCAbramsonMJImplementing clinical guidelines for chronic obstructive pulmonary disease: barriers and solutionsJ Thorac Dis20146111586159625478199
- DivoMJCasanovaCMarinJMBODE Collaborative GroupCOPD comorbidities networkEur Respir J201546364065026160874
- MaurerJRebbapragadaVBorsonSACCP Workshop Panel on Anxiety and Depression in COPDAnxiety and depression in COPD: current understanding, unanswered questions, and research needsChest20081344 suppl43S56S
- VanfleterenLEFranssenFMUszko-LencerNHFrequency and relevance of ischemic electrocardiographic findings in patients with chronic obstructive pulmonary diseaseAm J Cardiol2011108111669167422077976
- TriestFJFranssenFMSpruitMAGroenenMTWoutersEFVanfleterenLEPoor agreement between chart-based and objectively identified comorbidities of COPDEur Respir J20154651492149526341984
- VanfleterenLESpruitMAWoutersEFFranssenFMManagement of chronic obstructive pulmonary disease beyond the lungsLancet Respir Med201641191192427264777
- BrownJPMartinezCHChronic obstructive pulmonary disease comorbiditiesCurr Opin Pulm Med201622211311826814720
- HuangWCWuMFChenHCHsuJYTOLD GroupFeatures of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional studyNPJ Prim Care Respir Med2015251506326538368
- ZoggSDürrSMiedingerDStevelingEHMaierSLeuppiJDDifferences in classification of COPD patients into risk groups A-D: a cross-sectional studyBMC Res Notes2014756225148698